Please check your internet connection and try again.
# Acetylcysteine
## Overview
Acetylcysteine (NAC) is a mucolytic agent and an antidote for acetaminophen overdose. It is available in oral, intravenous, and inhalation formulations.
## Primary Indications
* **Acetaminophen Overdose:** Intravenous (IV) is the preferred route for acute overdose to prevent hepatotoxicity. Oral may be used if IV access is not immediately available or for specific protocols.
* **Mucolytic:** For conditions with thickened bronchial secretions (e.g., COPD, cystic fibrosis, pneumonia). Typically administered via nebulization.
## Adult Dosing
* **Acetaminophen Overdose (IV):**
* **Loading Dose:** 150 mg/kg IV infused over 1 hour.
* **Second Dose:** 50 mg/kg IV infused over 20 hours (total infusion time 21 hours).
* **Subsequent Doses:** 150 mg/kg IV infused over 20 hours.
* *Note:* Dosing is often guided by nomograms and hospital protocols, especially for late presentations or elevated AST/ALT. Higher doses may be used in severe cases.
* **Acetaminophen Overdose (Oral):**
* **Loading Dose:** 140 mg/kg PO.
* **Subsequent Doses:** 70 mg/kg PO every 4 hours for 17 doses (total 71 hours).
* *Note:* Oral NAC is less effective than IV due to lower bioavailability and potential for emesis. Antiemetics are often required.
* **Mucolytic (Nebulization):**
* 3-5 mL of 20% solution or 6-10 mL of 10% solution, nebulized every 4-12 hours as needed.
## Pediatric Dosing
* **Acetaminophen Overdose (IV):**
* Same as adult dosing: 150 mg/kg IV over 1 hour, followed by 50 mg/kg IV over 20 hours, then 100 mg/kg IV over 16 hours (adapted from adult protocol for a total of 21 hours).
* *Note:* Protocols for pediatric IV NAC dosing can vary; confirm with local guidelines.
* **Acetaminophen Overdose (Oral):**
* Same as adult dosing: 140 mg/kg PO, followed by 70 mg/kg PO every 4 hours for 17 doses.
* **Mucolytic (Nebulization):**
* **<1 year:** 2 mL of 10% solution or 1 mL of 20% solution every 2-6 hours.
* **1-2 years:** 2-4 mL of 10% solution or 1-2 mL of 20% solution every 2-6 hours.
* **>2 years:** 3-5 mL of 20% solution or 6-10 mL of 10% solution every 2-6 hours.
## Dose Adjustments
* **Hepatic Impairment:** No specific dose adjustment is typically recommended for acetaminophen overdose due to the goal of preventing further injury.
* **Renal Impairment:** No specific dose adjustment is typically recommended for acetaminophen overdose. For mucolytic use, monitor for efficacy.
## Contraindications
* Hypersensitivity to acetylcysteine.
* Oral formulation is contraindicated in patients with a suspected or confirmed esophageal obstruction.
## Adverse Effects
* **IV:** Anaphylactoid reactions (rash, urticaria, angioedema, bronchospasm, dyspnea, hypotension) are common and can occur even after repeated administrations. Nausea, vomiting, and flushing can also occur.
* **Oral:** Nausea, vomiting, diarrhea, stomatitis.
* **Nebulization:** Bronchospasm, nausea, vomiting, stomatitis, rhinorrhea.
## Key Drug Interactions
* **Activated Charcoal:** Decreases absorption of oral acetylcysteine. Administer NAC at least 1 hour after charcoal.
* **Nitroglycerin:** May potentiate the hypotensive effect of nitroglycerin.
## Monitoring
* **Acetaminophen Overdose:**
* Acetaminophen and its toxic metabolite (NAPQI) levels.
* Liver function tests (AST, ALT, bilirubin, INR).
* Renal function and electrolytes.
* Clinical signs of liver injury.
* **Mucolytic Use:**
* Respiratory status, sputum production, and airway patency.
* Bronchospasm (especially in asthmatics).
## Clinical Pearls
* For acetaminophen overdose, initiate NAC as soon as possible, even if the acetaminophen level is not yet available or if the time of ingestion is uncertain.
* Anaphylactoid reactions to IV NAC are common and typically managed with slowing the infusion rate and administering antihistamines. Discontinuation is usually not necessary unless severe.
* Ensure adequate hydration when administering oral NAC to prevent dehydration and facilitate passage.
* Consider acetylcysteine for indications other than acetaminophen overdose, such as contrast-induced nephropathy (though evidence is mixed and not a standard indication) or as an adjunct in some pulmonary conditions.
***
*This information is intended for healthcare professionals. It is essential to consult the most current prescribing information and relevant clinical guidelines before making any treatment decisions.*